To show the ability of IEC to directly modulate lymphocyte activation through CD80 signaling, we co-cultured IEC from healthy colonic mucosa with syngeneic lymphocytes extracted from pericolonic lymph nodes of patients undergoing surgery for non neoplastic disease and for colonic adenocarcinoma. The gene discussed is CD80; the disease is colon adenocarcinoma.